In the subsequently different pretreated colon cancer mouse model experiments, Western blot revealed that FOXN3 was expressed in the normal colon tissues and tumors, demonstrating the reduction in the level of FOXN3 protein. The gene discussed is FOXN3; the disease is malignant colon neoplasm.